Výsledky vyhledávání - "E N Prystowsky"

Effect of continuous enhanced vagal tone on atrioventricular nodal and sinoatrial nodal function in humans

Autor: Robert L. Page, A. S. L. Tang, E. N. Prystowsky

Publikováno v: Circulation Research. 68:1614-1620

A constant intravenous infusion of phenylephrine (0.74 +/- 0.41 micrograms/kg/min) was given to 10 patients to cause a continuous augmentation in reflex vagal tone. After the infusion, the diastolic blood pressure increased from 76 +/- 7 to 89 +/- 11

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::27601c1d009ce8c60bf0caf386a48a78
https://doi.org/10.1161/01.res.68.6.1614

Zobrazit plný text záznamu

Electrophysiology

Autor: J M Wharton, E N Prystowsky

Publikováno v: Current Opinion in Cardiology. 6:40-48

Though tachyarrhythmias occur commonly in patients with the Wolff-Parkinson-White syndrome, many patients remain asymptomatic. Recent studies suggest that routine electrophysiologic testing in these individuals is of limited value. However, electroph

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::cb6c7be1bcb0018244c7f70de51e58ca
https://doi.org/10.1097/00001573-199102000-00006

Zobrazit plný text záznamu

Atrial Fibrillation: New Insights into Electrophysiologic Mechanisms

Autor: B. J. Padanilam, E. N. Prystowsky

Publikováno v: New Advances in Heart Failure and Atrial Fibrillation ISBN: 9788847021693

Anyone who considers the mechanism(s) of a tachyarrhythmia in humans must address both potential arrhythmia triggers as well as anatomic substrate. The anatomic substrate includes not only alterations in the myocardial architecture (for example fibro

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::514e3b4400affdd69906373fff979d2a
https://doi.org/10.1007/978-88-470-2087-0_20

Zobrazit plný text záznamu

Primary and secondary prevention of sudden cardiac death: the role of the implantable cardioverter defibrillator

Autor: E N, Prystowsky

Publikováno v: Reviews in cardiovascular medicine. 2(4)

Sudden cardiac death (SCD) affects nearly 300,000 people each year in the U.S., and out-of-hospital rates for survival range from only 2% to 25%. A substantial reduction in SCD requires primary prevention through risk-stratification and secondary pre

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::c2a7b298d0d07ac0a015c8a72edc9136
https://pubmed.ncbi.nlm.nih.gov/12439369

Zobrazit plný text záznamu

Recurrence of symptomatic ventricular arrhythmias in patients with implantable cardioverter defibrillator after the first device therapy: implications for antiarrhythmic therapy and driving restrictions. CARE Group

Autor: N A, Freedberg, J N, Hill, R I, Fogel, E N, Prystowsky

Publikováno v: Journal of the American College of Cardiology. 37(7)

The purpose of this study was to investigate whether clinical or electrophysiologic characteristics could predict initial and subsequent implantable cardioverter defibrillator (ICD) therapy.Identification of markers to predict subsequent ICD therapy

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::1f96ed415b30ecf45f614d705b6c6f08
https://pubmed.ncbi.nlm.nih.gov/11401131

Zobrazit plný text záznamu

A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators

Autor: A E, Buxton, K L, Lee, J D, Fisher, M E, Josephson, E N, Prystowsky, G, Hafley

Publikováno v: The New England journal of medicine. 341(25)

Empirical antiarrhythmic therapy has not reduced mortality among patients with coronary artery disease and asymptomatic ventricular arrhythmias. Previous studies have suggested that antiarrhythmic therapy guided by electrophysiologic testing might re

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::4e4f7ba7886334e8479e5db5a58d1986
https://pubmed.ncbi.nlm.nih.gov/11185602

Zobrazit plný text záznamu

Implantable defibrillator event rates in patients with unexplained syncope and inducible sustained ventricular tachyarrhythmias: a comparison with patients known to have sustained ventricular tachycardia

Autor: N P, Andrews, R I, Fogel, G, Pelargonio, J J, Evans, E N, Prystowsky

Publikováno v: Journal of the American College of Cardiology. 34(7)

To assess the clinical significance of inducible ventricular tachyarrhythmias among patients with unexplained syncope.Induction of sustained ventricular arrhythmias at electrophysiology study in patients with unexplained syncope and structural heart

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::3003567b1839117e97c19aea012c36c1
https://pubmed.ncbi.nlm.nih.gov/10588219

Zobrazit plný text záznamu

Prevention of implantable-defibrillator shocks by treatment with sotalol. d,l-Sotalol Implantable Cardioverter-Defibrillator Study Group

Autor: A, Pacifico, S H, Hohnloser, J H, Williams, B, Tao, S, Saksena, P D, Henry, E N, Prystowsky

Publikováno v: The New England journal of medicine. 340(24)

Patients with implantable cardioverter-defibrillators often receive adjunctive antiarrhythmic therapy to prevent frequent shocks. We tested the efficacy and safety of sotalol, a beta-blocker with class III antiarrhythmic effects, for this purpose.In

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::88cd220639d794602505b4498907bfad
https://pubmed.ncbi.nlm.nih.gov/10369855

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání